实验方案(Protocols)

Recombinant Human GNA13 Protein: Handling & Application Protocol

Recombinant Human GNA13 Protein is a critical reagent for investigating heterotrimeric G-protein alpha-13 subunit signaling pathways, enabling researchers to dissect RhoA activation, cytoskeletal remodeling, and oncogenic signal transduction in vitro.

Product Name
Recombinant Human GNA13 Protein
SKU
rp375096
Protein Target
GNA13 (Guanine Nucleotide-Binding Protein Subunit Alpha-13)
Species
Human (Homo sapiens)
Application
Biochemical assays, G-protein signaling studies, RhoGEF interaction assays, in vitro functional studies
Storage Recommendation
Avoid repeated freeze-thaw cycles; aliquot upon reconstitution and store at -80°C for long-term use
Supplier Reference
absea#PP-8830

Background and Biological Significance of GNA13

GNA13 encodes the alpha-13 subunit (Gα13) of heterotrimeric G-proteins, a member of the G12 family that couples with specific G-protein-coupled receptors (GPCRs) to transduce extracellular signals into intracellular responses. Upon GPCR activation, Gα13 exchanges GDP for GTP and dissociates from the Gβγ dimer to activate downstream effectors, most notably Rho guanine nucleotide exchange factors (RhoGEFs) such as p115-RhoGEF, PDZ-RhoGEF, and LARG, ultimately leading to RhoA activation.

RhoA activation downstream of GNA13 regulates cytoskeletal reorganization, cell migration, proliferation, and survival. GNA13 has been implicated in oncogenesis—particularly in diffuse large B-cell lymphoma (DLBCL) and other hematological malignancies—as well as in platelet aggregation, vascular development, and inflammatory signaling. Recombinant Human GNA13 Protein (rp375096) provides a well-defined biochemical tool for mechanistic studies of these pathways.

Materials Required

Before beginning the protocol, ensure the following materials are available:

  • Recombinant Human GNA13 Protein (Aladdin Scientific, SKU: rp375096)
  • Sterile, nuclease-free deionized water or recommended reconstitution buffer (refer to the Certificate of Analysis supplied with the product lot)
  • Phosphate-buffered saline (PBS), pH 7.4, optionally supplemented with a carrier protein (e.g., 0.1% BSA) to enhance protein stability during dilution
  • Low-binding microcentrifuge tubes (1.5 mL)
  • Micropipettes and calibrated tips
  • -20°C and -80°C freezers
  • SDS-PAGE and Western blot apparatus (for QC verification)
  • Appropriate downstream assay reagents (e.g., GTPase activity assay kit, RhoA activation assay, co-immunoprecipitation buffers)

Note: Refer to the product-specific Certificate of Analysis (CoA) for lot-specific formulation details, including recommended reconstitution volume and buffer composition, as these may vary by production lot.

Step-by-Step Reconstitution and Storage Protocol

  1. Thawing: Remove the vial of Recombinant Human GNA13 Protein from the freezer and allow it to equilibrate briefly at room temperature (no more than 5 minutes) or thaw gently on ice. Do not heat.
  2. Centrifugation: Briefly centrifuge the vial (e.g., 2,000 × g for 10–15 seconds) to collect any lyophilized material or condensate from the walls and cap before opening.
  3. Reconstitution: Add the recommended volume of sterile reconstitution buffer or nuclease-free water as specified in the CoA. Gently pipette up and down to mix—do not vortex vigorously, as this may denature the protein. Allow the solution to stand for 5–10 minutes at room temperature to ensure complete dissolution.
  4. Aliquoting: Divide the reconstituted protein into single-use aliquots in low-binding tubes to minimize freeze-thaw cycles. Label each aliquot with protein concentration, date, and lot number.
  5. Short-term storage: Store working aliquots at 4°C for up to 48–72 hours if immediate use is planned.
  6. Long-term storage: Store aliquots at -80°C. Avoid repeated freeze-thaw cycles, as these significantly reduce protein activity and integrity. Each freeze-thaw cycle may result in measurable loss of functional activity.
  7. Working concentrations: Determine optimal working concentrations empirically for each assay system. Starting ranges should be established based on the literature for GNA13-dependent assays and validated using activity or binding controls.

Review flag: Specific reconstitution buffer composition and recommended concentration for rp375096 are not provided in the source material; consult the product CoA and contact Aladdin Scientific technical support for lot-specific details.

Experimental Applications and Quality Control

Quality Control Verification: Prior to use in functional assays, verify protein identity and purity by SDS-PAGE under denaturing conditions. The expected molecular weight of GNA13 is approximately 44 kDa. Western blot analysis using a validated anti-GNA13 antibody can confirm protein identity. Assess purity visually from Coomassie-stained gels.

Recommended Applications:

  • GTPase Activity Assays: Recombinant GNA13 protein can be used in malachite green or radiolabeled GTP hydrolysis assays to characterize intrinsic and RGS-protein-stimulated GTPase activity.
  • Protein–Protein Interaction Studies: Use in pull-down assays or surface plasmon resonance (SPR) to characterize interactions with RhoGEF partners (e.g., p115-RhoGEF, LARG) or RGS domain-containing proteins.
  • RhoA Activation Assays: Incorporate GNA13 into reconstituted in vitro systems to assess its ability to stimulate RhoGEF-mediated RhoA nucleotide exchange.
  • Structural and Biophysical Studies: Suitable as a biochemical reference for crystallography, cryo-EM sample preparation, or biophysical characterization (e.g., circular dichroism, thermal shift assay).

Note: Working concentrations and assay conditions should be optimized empirically. Include appropriate positive and negative controls in all experiments.

Troubleshooting

ProblemPossible CauseSuggested Solution
No or low activity in GTPase assayProtein denaturation due to improper handling or freeze-thaw damageEnsure proper thawing on ice; use freshly reconstituted aliquots; verify protein integrity by SDS-PAGE
Multiple bands on SDS-PAGEProtein degradation or aggregationCheck storage temperature; use fresh aliquots; add protease inhibitors to buffers if applicable
Poor solubility after reconstitutionInsufficient reconstitution time or incorrect bufferAllow 10 minutes for dissolution; use the buffer specified in the CoA; avoid vortexing
Non-specific background in interaction assaysExcessive protein concentration or non-optimized assay conditionsTitrate protein concentration; optimize salt and detergent concentrations in binding buffer

Frequently asked questions

What is the biological function of GNA13 and why is it relevant for cancer research?

GNA13 (Gα13) is a heterotrimeric G-protein alpha subunit that transduces signals from GPCRs to activate RhoGEFs and downstream RhoA signaling, regulating cell migration, proliferation, and survival. Loss-of-function mutations in GNA13 have been identified in diffuse large B-cell lymphoma (DLBCL) and other lymphomas, making it a relevant target for oncology research.

How should I store Recombinant Human GNA13 Protein to maintain activity?

Upon receipt, store the protein at -80°C for long-term preservation. After reconstitution, divide into single-use aliquots and store at -80°C. Avoid repeated freeze-thaw cycles, as each cycle can reduce protein activity. Working aliquots may be kept at 4°C for up to 48–72 hours.

What quality control tests should I perform before using rp375096 in a functional assay?

Before functional use, verify protein identity and purity by SDS-PAGE under reducing conditions—GNA13 has an expected molecular weight of approximately 44 kDa. Confirm identity by Western blot with a validated anti-GNA13 antibody. If available, an in vitro GTPase activity assay can confirm functional integrity of the recombinant protein.

Can Recombinant Human GNA13 Protein be used for in vivo studies?

Recombinant Human GNA13 Protein (rp375096) is intended for in vitro research use only and is not approved for therapeutic, diagnostic, or in vivo applications in humans or animals. Researchers should consult the product documentation and applicable regulations before designing any study.

References

  1. Bhatt DL et al. G-protein alpha-13 (GNA13) in hematological malignancies — general review of G12 family signaling. [Review flag: specific citation not provided in source material; representative reference needed]
  2. Remmers AE et al. Regulation of G alpha 13- and Rho-dependent cell transformation by p115 Rho GEF. [Review flag: author names and details are illustrative; verify against primary literature]
  3. Aladdin Scientific. Recombinant Human GNA13 Protein, SKU rp375096. Product datasheet and Certificate of Analysis.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human GNA13 Protein: Handling & Application Protocol》. 阿拉丁知识库,更新于 2026年10月30日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-gna13-protein-handling-application-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 4 人觉得有帮助